Search research articles
Contact Us
Filters
Showing results (221-230 of 332) with videos related to
Page
of 34
Sort By:
Clinical Genetics
|
December 21, 2024
Effectiveness and Impact of Transcript Analysis in Clinical Genetics Daily Practice
Giovanni Innella, Emanuele Coccia, Carlotta Pia Cristalli, et al.
Frontiers in Genetics
|
June 20, 2022
Case Report: Optic Atrophy and Nephropathy With m.13513G>A/MT-ND5 mtDNA Pathogenic Variant
Valentina Barone, Chiara La Morgia, Leonardo Caporali, et al.
Journal of Cellular and Molecular Medicine
|
January 21, 2021
An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder
Cinzia Cameli, Marta Viggiano, Magali J Rochat, et al.
Translational Vision Science & Technology
|
June 10, 2025
Machine Learning Applied to Visual Fields of Dominant Optic Atrophy Patients
Catarina P Coutinho, Ferdinando Zanchetta, Michele Carbonelli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 2007
Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors
Giuseppe Gasparre, Anna Maria Porcelli, Elena Bonora, et al.
NPJ Genomic Medicine
|
March 23, 2024
Genomic analysis of 116 autism families strengthens known risk genes and highlights promising candidates
Marta Viggiano, Fabiola Ceroni, Paola Visconti, et al.
Journal of Internal Medicine
|
February 27, 2026
Collagen and microvascular alterations contribute to neuromuscular degeneration and disease progression in chronic intestinal pseudo-obstruction
Elisa Boschetti, Irene Neri, Leonardo Caporali, et al.
Sleep Medicine
|
April 9, 2014
Polysomnographic and neurometabolic features may mark preclinical autosomal dominant cerebellar ataxia, deafness, and narcolepsy due to a mutation in the DNA (cytosine-5-)-methyltransferase gene, DNMT1
Keivan Kaveh Moghadam, Fabio Pizza, Caterina Tonon, et al.
Brain : a Journal of Neurology
|
June 28, 2014
Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier
Tobias Bonifert, Kathrin N Karle, Felix Tonagel, et al.
Annals of Clinical and Translational Neurology
|
May 5, 2021
Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations
Laura L Gramegna, Stefania Evangelisti, Lidia Di Vito, et al.
Page
of 34
Search research articles
Search
Showing results (221-230 of 332) with videos related to
Sort By:
Page
of 34
Clinical Genetics
|
December 21, 2024
Effectiveness and Impact of Transcript Analysis in Clinical Genetics Daily Practice
Giovanni Innella, Emanuele Coccia, Carlotta Pia Cristalli, et al.
Frontiers in Genetics
|
June 20, 2022
Case Report: Optic Atrophy and Nephropathy With m.13513G>A/MT-ND5 mtDNA Pathogenic Variant
Valentina Barone, Chiara La Morgia, Leonardo Caporali, et al.
Journal of Cellular and Molecular Medicine
|
January 21, 2021
An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder
Cinzia Cameli, Marta Viggiano, Magali J Rochat, et al.
Translational Vision Science & Technology
|
June 10, 2025
Machine Learning Applied to Visual Fields of Dominant Optic Atrophy Patients
Catarina P Coutinho, Ferdinando Zanchetta, Michele Carbonelli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 2007
Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors
Giuseppe Gasparre, Anna Maria Porcelli, Elena Bonora, et al.
NPJ Genomic Medicine
|
March 23, 2024
Genomic analysis of 116 autism families strengthens known risk genes and highlights promising candidates
Marta Viggiano, Fabiola Ceroni, Paola Visconti, et al.
Journal of Internal Medicine
|
February 27, 2026
Collagen and microvascular alterations contribute to neuromuscular degeneration and disease progression in chronic intestinal pseudo-obstruction
Elisa Boschetti, Irene Neri, Leonardo Caporali, et al.
Sleep Medicine
|
April 9, 2014
Polysomnographic and neurometabolic features may mark preclinical autosomal dominant cerebellar ataxia, deafness, and narcolepsy due to a mutation in the DNA (cytosine-5-)-methyltransferase gene, DNMT1
Keivan Kaveh Moghadam, Fabio Pizza, Caterina Tonon, et al.
Brain : a Journal of Neurology
|
June 28, 2014
Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier
Tobias Bonifert, Kathrin N Karle, Felix Tonagel, et al.
Annals of Clinical and Translational Neurology
|
May 5, 2021
Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations
Laura L Gramegna, Stefania Evangelisti, Lidia Di Vito, et al.
Page
of 34